A
SNDX icon

AlphaQuest’s Syndax Pharmaceuticals SNDX Stock Holding History

AlphaQuest’s Portfolio SNDX Stock Details SNDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-13,921
Closed -$292K – 1783
2025
Q4 		$292K Sell
13,921
-45,420
-77% -$792K 0.02% 1226
2025
Q3 		$913K Buy
59,341
+38,394
+183% +$503K 0.06% 472
2025
Q2 		$196K Sell
20,947
-18,370
-47% -$202K 0.02% 1143
2025
Q1 		$483K Buy
39,317
+15,694
+66% +$221K 0.05% 536
2024
Q4 		$312K Buy
23,623
+5,765
+32% +$98.7K 0.04% 693
2024
Q3 		$344K Buy
17,858
+4,223
+31% +$87.2K 0.03% 835
2024
Q2 		$280K Buy
13,635
+7,928
+139% +$166K 0.04% 655
2024
Q1 		$136K Buy
+5,707
New +$127K 0.02% 753

Other funds holding SNDX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return

AlphaQuest's SNDX Position: Q1 2026 in Review

AlphaQuest sold out of Syndax Pharmaceuticals (SNDX) in Q1 2026, closing a stake of 13,921 shares — an estimated $292K sold.

AlphaQuest first reported a position in SNDX in Q1 2024 and held it in 8 quarters. The position peaked at $913K in Q3 2025. 246 funds tracked by Wall St. Rank hold SNDX as of Q1 2026.

  • AlphaQuest reported no remaining Syndax Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • AlphaQuest sold 13,921 Syndax Pharmaceuticals shares in Q1 2026, an estimated $292K.
  • AlphaQuest first reported a position in Syndax Pharmaceuticals in Q1 2024 and held it in 8 quarters.
  • AlphaQuest's Syndax Pharmaceuticals position peaked at $913K in Q3 2025.
  • 246 funds tracked by Wall St. Rank held Syndax Pharmaceuticals as of Q1 2026.

Based on AlphaQuest's 13F filing for Q1 2026.